Tong Ren Tang Technologies Co. Ltd. (1666.HK)
HKD 4.67
(1.52%)
HKD 4.67
(1.52%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.3 Billion CNY | 8.16% |
| 2022 | 1.39 Billion CNY | 10.91% |
| 2021 | 1.25 Billion CNY | 10.05% |
| 2020 | 1.14 Billion CNY | 9.33% |
| 2019 | 1.04 Billion CNY | -18.6% |
| 2018 | 1.28 Billion CNY | 2.67% |
| 2017 | 1.24 Billion CNY | 15.26% |
| 2016 | 1.08 Billion CNY | 13.62% |
| 2015 | 953.37 Million CNY | 23.98% |
| 2014 | 768.98 Million CNY | 18.49% |
| 2013 | 648.97 Million CNY | 21.89% |
| 2012 | 531.74 Million CNY | 34.06% |
| 2011 | 381.32 Million CNY | 27.96% |
| 2010 | 310.35 Million CNY | 15.79% |
| 2009 | 268.03 Million CNY | 34.77% |
| 2008 | 246.01 Million CNY | 7.95% |
| 2007 | 184.23 Million CNY | 6.28% |
| 2006 | 173.34 Million CNY | -32.9% |
| 2005 | 256.61 Million CNY | 12.81% |
| 2004 | 230.03 Million CNY | 20.15% |
| 2003 | 190.59 Million CNY | 31.54% |
| 2002 | 144.89 Million CNY | 69.81% |
| 2001 | 85.32 Million CNY | 25.87% |
| 2000 | 67.79 Million CNY | 12.73% |
| 1999 | 60.13 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 726.97 Million CNY | 0.0% |
| 2023 Q4 | 569.08 Million CNY | 0.0% |
| 2023 Q2 | 733.24 Million CNY | 0.0% |
| 2023 FY | - CNY | 8.16% |
| 2022 Q2 | 650.43 Million CNY | 0.0% |
| 2022 Q4 | 741.89 Million CNY | 0.0% |
| 2022 FY | - CNY | 10.91% |
| 2021 FY | - CNY | 10.05% |
| 2021 Q2 | 673.06 Million CNY | 0.0% |
| 2021 Q4 | 582.32 Million CNY | 0.0% |
| 2020 Q2 | 558.7 Million CNY | 0.0% |
| 2020 FY | - CNY | 9.33% |
| 2020 Q4 | 582.02 Million CNY | 0.0% |
| 2019 FY | - CNY | -18.6% |
| 2019 Q4 | 306.79 Million CNY | 0.0% |
| 2019 Q2 | 736.62 Million CNY | 0.0% |
| 2018 Q2 | 770.17 Million CNY | 0.0% |
| 2018 FY | - CNY | 2.67% |
| 2018 Q4 | 511.7 Million CNY | 0.0% |
| 2017 FY | - CNY | 15.26% |
| 2017 Q4 | 511.4 Million CNY | 0.0% |
| 2017 Q2 | 737.1 Million CNY | 0.0% |
| 2016 Q2 | 711.76 Million CNY | 0.0% |
| 2016 Q4 | 371.44 Million CNY | 0.0% |
| 2016 FY | - CNY | 13.62% |
| 2015 FY | - CNY | 23.98% |
| 2015 Q4 | 371.88 Million CNY | 0.0% |
| 2015 Q2 | 581.49 Million CNY | 0.0% |
| 2014 Q4 | 297.91 Million CNY | 0.0% |
| 2014 Q2 | 471.07 Million CNY | 0.0% |
| 2014 FY | - CNY | 18.49% |
| 2013 Q2 | 391.27 Million CNY | 0.0% |
| 2013 Q4 | 257.7 Million CNY | 0.0% |
| 2013 FY | - CNY | 21.89% |
| 2012 FY | - CNY | 34.06% |
| 2012 Q1 | 115.76 Million CNY | 0.0% |
| 2012 Q2 | 115.76 Million CNY | 0.0% |
| 2012 Q3 | 115.76 Million CNY | 0.0% |
| 2012 Q4 | 134.89 Million CNY | 16.52% |
| 2011 Q4 | 115.76 Million CNY | 31.39% |
| 2011 FY | - CNY | 27.96% |
| 2011 Q3 | 88.1 Million CNY | 0.0% |
| 2011 Q2 | 88.1 Million CNY | 0.0% |
| 2011 Q1 | 88.1 Million CNY | 0.0% |
| 2010 Q4 | 88.1 Million CNY | 24.26% |
| 2010 Q3 | 70.9 Million CNY | 0.0% |
| 2010 Q1 | 70.9 Million CNY | 0.0% |
| 2010 Q2 | 70.9 Million CNY | 0.0% |
| 2010 FY | - CNY | 15.79% |
| 2009 Q4 | 70.9 Million CNY | 10.3% |
| 2009 Q1 | 64.28 Million CNY | 0.0% |
| 2009 Q2 | 64.28 Million CNY | 0.0% |
| 2009 FY | - CNY | 34.77% |
| 2009 Q3 | 64.28 Million CNY | 0.0% |
| 2008 Q1 | 47.75 Million CNY | 0.0% |
| 2008 Q3 | 47.75 Million CNY | 0.0% |
| 2008 Q4 | 64.28 Million CNY | 34.6% |
| 2008 FY | - CNY | 7.95% |
| 2008 Q2 | 47.75 Million CNY | 0.0% |
| 2007 Q3 | 46.02 Million CNY | 0.0% |
| 2007 Q2 | 46.02 Million CNY | 0.0% |
| 2007 Q1 | 46.02 Million CNY | 0.0% |
| 2007 Q4 | 47.75 Million CNY | 3.77% |
| 2007 FY | - CNY | 6.28% |
| 2006 Q2 | 42.8 Million CNY | 0.0% |
| 2006 Q3 | 42.8 Million CNY | 0.0% |
| 2006 Q1 | 42.8 Million CNY | 0.0% |
| 2006 Q4 | 46.02 Million CNY | 7.51% |
| 2006 FY | - CNY | -32.9% |
| 2005 Q2 | 64.25 Million CNY | 0.0% |
| 2005 FY | - CNY | 12.81% |
| 2005 Q3 | 64.25 Million CNY | 0.0% |
| 2005 Q4 | 42.8 Million CNY | -33.38% |
| 2005 Q1 | 64.25 Million CNY | 0.0% |
| 2004 Q2 | 55.52 Million CNY | 0.0% |
| 2004 Q3 | 55.52 Million CNY | 0.0% |
| 2004 FY | - CNY | 20.15% |
| 2004 Q4 | 64.25 Million CNY | 15.72% |
| 2004 Q1 | 55.52 Million CNY | 0.0% |
| 2003 Q4 | 55.52 Million CNY | 17.98% |
| 2003 Q1 | 47.06 Million CNY | 0.0% |
| 2003 Q3 | 47.06 Million CNY | 0.0% |
| 2003 Q2 | 47.06 Million CNY | 0.0% |
| 2003 FY | - CNY | 31.54% |
| 2002 Q1 | 35.98 Million CNY | 0.0% |
| 2002 FY | - CNY | 69.81% |
| 2002 Q2 | 35.98 Million CNY | 0.0% |
| 2002 Q3 | 35.98 Million CNY | 0.0% |
| 2002 Q4 | 47.06 Million CNY | 30.8% |
| 2001 FY | - CNY | 25.87% |
| 2001 Q4 | 35.98 Million CNY | 54.75% |
| 2001 Q3 | 23.25 Million CNY | 0.0% |
| 2001 Q2 | 23.25 Million CNY | 0.0% |
| 2001 Q1 | 23.25 Million CNY | 0.0% |
| 2000 FY | - CNY | 12.73% |
| 2000 Q4 | 23.25 Million CNY | 39.6% |
| 2000 Q1 | 16.65 Million CNY | 0.0% |
| 2000 Q2 | 16.65 Million CNY | 0.0% |
| 2000 Q3 | 16.65 Million CNY | 0.0% |
| 1999 Q3 | 14.27 Million CNY | 0.0% |
| 1999 FY | - CNY | 0.0% |
| 1999 Q4 | 16.65 Million CNY | 16.68% |
| 1999 Q2 | 14.27 Million CNY | 0.0% |
| 1999 Q1 | 14.27 Million CNY | 0.0% |
| 1998 Q4 | 14.27 Million CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 8.53 Billion HKD | 84.737% |